Rare diseases
Investigational molecules
Locations
Back to Spain1 052 clinical trials in Malaga, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
SpainStudy of DBV712 skin patch safety in children aged 1-3 years with peanut allergy
SpainStudy of Cromolyn Inhalation Treatment for Patients with Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)
SpainStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
SpainStudy of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
SpainStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
SpainStudy of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis
SpainStudy comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus
SpainStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
SpainStudy of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria
SpainStudy comparing valemetostat tosylate plus pembrolizumab versus pembrolizumab alone in patients with advanced non-small cell lung cancer with high PD-L1 expression
SpainStudy of Zelenectide Pevedotin in Adults with Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer with NECTIN4 Amplification
SpainThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for cutaneous lupus erythematosus and myasthenia gravis, evaluating new therapeutic approaches to improve patient outcomes.
Studies aim to assess novel therapies' effectiveness in reducing disease activity and improving daily living activities.
Innovative vaccine development studies targeting COVID-19, cytomegalovirus, and respiratory syncytial virus, focusing on prevention and immune response.
Research emphasizes safety and immunogenicity in various population groups.
Advanced studies in bladder cancer, colorectal cancer, and gastric cancer, evaluating targeted therapies and combination treatments.
Trials focus on improving survival rates and treatment responses in various cancer types.
Research examining new treatments for chronic rhinosinusitis and COPD, with emphasis on symptom management and exacerbation prevention.
Studies evaluate novel therapeutic approaches for chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
